Neutral
AptarGroup reported robust 20% growth in its injectable component sales for Q1 2026, driven by high demand for GLP-1 drugs and biologics. This strong ...
Neutral
Comerica Bank lifted its holdings in shares of AptarGroup, Inc. (NYSE:ATR – Free Report) by 57.4% during the fourth quarter, HoldingsChannel reports. ...
AptarGroup reported an 11% increase in Q1 2026 net sales to $982.9 million, but net income and diluted EPS decreased due to softer profit metrics and ...